Table 3.
Event | Number | % |
---|---|---|
Up to 1 month follow-up | ||
Death (total) | 1 | 0.4 |
Cardiovascular death | 1 | 0.4 |
Stent thrombosis | 1 | 0.4 |
Total major clinical events | 2 | 0.8 |
From 1 month to 1 year follow-up | ||
Death (total) | 11 | 4.4 |
Cardiovascular death | 4 | 1.6 |
Death due to renal failure | 3 | 1.2 |
Pulmonary death | 1 | 0.4 |
MI | 1 | 0.4 |
Target lesion revascularization | 2 | 0.8 |
Total Events up to 1 year | ||
Total major adverse events up to 1 year follow-up | 16 | 6.4 |
Total number of patients with major adverse events up to 1 year follow-up | 15 | 6.0 |
Total major adverse events up to 1 year follow-up related to device or procedure | 6 | 2.4 |